Article here:
Findings of Scientific Misconduct
Clinical trial data for:
“Gonadotrophin-releasing hormone agonist plus estrogen-progestin ‘add-back’ therapy for endometriosis-related pelvic pain.” Fertility and Sterility 30:236-41, 1993.”
“To evaluate the safety and efficacy of leuprolide acetate depot (LA, Lupron; TAP Pharmaceuticals, Deerfield, IL) plus daily conjugated equine estrogens (Es, Premarin; Wyeth-Ayerst Laboratories, Philadelphia, PA), and medroxyprogesterone acetate (MPA, Provera; The Upjohn Company, Kalamazoo, MI) “add-back” treatment of endometriosis-associated pelvic pain.”
